• Skip to main content
  • Skip to primary sidebar
Transfusion News
  • About Us
  • Topics
    • Adverse Events (non-infectious)
    • Blood Donation
    • Cell Therapy
    • Coagulation & Plasma Transfusion
    • Platelet Transfusion
    • Policy and Guidelines
    • Quality Control and Regulatory
    • RBC Transfusion
    • Serology/Genotyping
    • Special Transfusion Situations
    • Transfusion Transmitted Infections
  • Continuing Education
  • Archives
  • Podcasts
  • Question of the Day
  • Search
  • Subscribe to Email Alerts
  • Follow us on
  • Search
  • Subscribe to Email Alerts

Adverse Events (non-infectious)

Convalescent Plasma for COVID-19 Safe in First 5,000 Patients

With limited therapies for patients with COVID-19 and a mortality rate of approximately 50% for patients in the ICU, demand…

May 19, 2020

National Survey Finds Stable Adverse Transfusion Reaction Rate in the U.S.

The 2017 National Blood Collection and Utilization Survey (NBCUS) used a web-based survey of approximately 3,000 U.S. community-based and hospital-based…

March 11, 2020

Risk Factors for Hyperhemolysis Syndrome Identified

Hyperhemolysis Syndrome (HS) is a rare, potentially fatal condition characterized by the development of severe anemia after transfusion in which…

October 16, 2019

Increased Risk of Transfusion Reactions in Postpartum Blood Transfusions

Transfusion reactions occur in 0.15% to 3.7% of all transfusions and can range from mild fevers to severe, life-threatening reactions….

August 28, 2019

The Role of Osteopontin in Murine TRALI

Osteopontin (OPN) is a proinflammatory, multifunctional protein with both physiological and pathological roles. Since OPN attracts neutrophils, which are involved…

July 11, 2019

New Criteria for Transfusion-Associated Circulatory Overload (TACO)

  Transfusion-associated circulatory overload (TACO) is one of the major causes of death associated with transfusions. TACO is characterized by…

May 21, 2019

Delayed Hemolytic Transfusion Reactions are Under Diagnosed in Patients with Sickle Cell Disease

Red blood cell transfusions are often used to treat patients with sickle cell disease (SCD), and these patients are at…

May 1, 2019

Locus on Chromosome 5 Associated with Alloimmunization

Red blood cell (RBC) transfusion remains the cornerstone for treating patients with sickle cell disease (SCD). While most patients with…

January 9, 2019

Electronic Scanning of Patient Wristbands Reduces Chance of ABO-Incompatible Transfusions

ABO-incompatible transfusions can be life-threatening to patients and are often attributable to human errors. Wrong blood in tube (WBIT) errors…

December 19, 2018

Older RBCs Associated with Increased Risk of Death Among Trauma Patients

Current regulations allow red blood cells (RBCs) to be stored and used for up to 42 days. During this time,…

November 27, 2018

  • « Go to Previous Page
  • Page 1
  • Page 2
  • Page 3
  • Page 4
  • Interim pages omitted …
  • Page 6
  • Go to Next Page »

Primary Sidebar

Latest News

  • 2024 Serious Hazards of Transfusions (SHOT) Report in the U.K.

  • Machine Learning Model for Estimating Perioperative Transfusion Risks

  • Blood Transfusion Strategies for Major Trauma

  • Storage Duration Affects Hematological and Metabolic Parameters in Patients with Sickle Cell Disease

    Question of the Day

    Copyright © 2025 John Wiley & Sons, Inc. All Rights Reserved.
    Privacy Policy

    Association for the Advancement of Blood and Biotherapies Wiley